期刊文献+

羊布鲁菌强毒株16M与疫苗株M5外膜蛋白蛋白质组学研究 被引量:3

A comparative proteomics study on OMPs between Brucella melitensis 16M and M5
原文传递
导出
摘要 通过比较蛋白质组学分析M5生存表型的改变所引起的蛋白图谱与强毒株的差异之处,根据这些差异表达蛋白的LC/MS-MS鉴定结果来分析疫苗株的致弱机制进而为寻找新的毒力相关分子、鉴别诊断分子以及揭示布鲁菌胞内寄生机制提供帮助。本研究利用比较蛋白质组学技术,对布鲁菌强毒株16 M和弱毒株M5的外膜蛋白进行了差异比较分析,结果共发现33个差异蛋白点,代表了26个开放阅读框,这些蛋白涉及了蛋白质的生物合成(5/26)、氨基酸合成(3/26),脂肪酸代谢(2/26)、能量代谢(5/26),以及细胞被膜生物合成(4/26)和一些调节系统(4/26)等多个生物过程。这些发现为研究外膜蛋白在布鲁菌毒力,胞内寄生等过程中发挥的重要作用提供了新依据。 A comparative analysis of the outer membrane proteins of Brucella melitensis 16M and M5 was performed using two-dimensional gel electrophoresis and the proteins of interest were identified using LC-MS/MS,which would be helpful for us to find new virulent factors,differential diagnosis molecules and reveal the intracellular survival mechanism for Burcella spp in host cell.In this study,a difference map was created for B.melitensis 16M and M5 containing 33 entries proteins,which represent 26 discrete open reading frames(ORFs) and are closely correlated with a number of bioprocesses,such as protein synthesis,amino-acid-biosynthesis,cell-wallbiogenesis,energy-metabolism,regulatory functions,fatty acid and phospholipid metabolism.These findings would provide insight for the roles of Brucella Omps about bacterial virulence and intracellular survival.
出处 《中国兽医学报》 CAS CSCD 北大核心 2010年第10期1334-1342,共9页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目(30972198/C180503) 中国科学院病原微生物与免疫学重点实验室开放基金资助项目(2009CASPMI-006)
关键词 羊布鲁菌 外膜蛋白 比较蛋白质组学 双向电泳 液相色谱串联质谱 Brucella melitensis OMPs comparative proteome two-dimension electrophoresis(2DE) LC-MS/MS
  • 相关文献

参考文献25

  • 1Seleem M N, Boyle S M, Sriranganathan N, Brucellosis: a re-emerging zoonosis[J].Vet Microbiol, 2010, 140:392-398.
  • 2Splitter G, Oliveira S, Carey M, et al. T lymphocyte mediated protection against facultative intraeellular bacteria[J]. Vet Immunol Immunopathol, 1996, 54: 309-319.
  • 3Blasco J M. A reviewof the use of Brucella melitensis Rev. 1 vaccine in adult sheepand goats[J].Prey Vet Med, 1997,31 : 275-283.
  • 4Jimenez de Bagues M P,Marin C M,Blasco J M,et al. An ELISAwith Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev. [J].Vet Microbiol, 1992,30:233-241.
  • 5Adone R, Francia M, Ciuehini F. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B.ovis infections[J]. Vaccine, 2008,26: 4913-4917.
  • 6Robinson A, Melling J. Envelope structure and the development of new vaccines[J].J Appl Bacterial, 1993, 74 suppl:43-51.
  • 7特怀曼RM.蛋白质组学原理[M].王恒樑,译.北京:化学工业出版社,2007.
  • 8Eschenbrenner M,Wagner M A, Horn T A,et al. Comparative proteome analysis of Brucella melitensis vaccine st rain Rev 1 and a virulent st rain 16M[J]. J Bacteriol,2002,184(18) :4962-4970.
  • 9Molloy M P. Isolation of bacterial cell membranes proteins using carbonate extraction[J]. Methods Molecul Biol, 2008,424 : 397-402.
  • 10Henningsen R G B,Straub K M. Application of zwitterionic detergents to the solubilization of integral membrane proteins for two-dimensional gel electrophgresis and mass spectrometry[J].Proteomics,2002 (2) : 1479-1488.

二级参考文献23

  • 1丁家波,毛开荣,程君生,戴志红,蒋玉文.布氏杆菌病疫苗的应用和研究现状[J].微生物学报,2006,46(5):856-859. 被引量:56
  • 2Ariza J. Brucellosis: an update. The perspective from the Mediterranean basin. Reviews in medical microbiology, 1999, 10: 125- 135.
  • 3Diptee MD, Adesiyun AA, Asgarali Z, et al. Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis). Veterinary immunology and immunopathology, 2006,109( 1 - 2 ) : 43 - 55.
  • 4Lopetegui P. Bovine brucellosis control and eradication programme in Chile: vaccine use as a tool within the programme. Developmental biology ( Basel ) ,2004,119:473 - 479.
  • 5Mustafa AA, Abusowa MF. Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya. Veterinary research, 1993,24(5) : 422 - 429.
  • 6Ignacio M, Marfa JG, Daniel M, et al. Rough vaccines in animal brucellosis: Structural and genetic basis and present status. Veterinary research, 2004,35 : 1 - 38
  • 7Godfroid F,Cloeckaert A,Taminiau B, et al. Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of brucella melitensis 16M (wbk). Research in microbiology, 2000, 151 (8): 655 - 68.
  • 8Vemulapalli R, McQuiston JR., Schurig GG, et al. Identification of and IS711 element interrupting the whoA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clinical diagnostic laboratory immunology, 1999,6:760 - 764.
  • 9DelVecchio V G, Kapatral V, Redkar R J, et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis[J]. Proc. Natl. Acad. Sci. ,2002,99:443-448.
  • 10Wagner M A, Eschenbrenner M, DelVecchio V G, et al. Global analysis of the Brucella melitensis proteome: identification of proteins expressed in laboratory-grown culture[J]. Proteomics, 2002, 2: 1047-1060.

共引文献20

同被引文献20

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部